Inari Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NARI research report →
About the company
Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis.
- CEO
- Kevin Strange
- IPO
- 2020
- Employees
- 1,300
- HQ
- Irvine, CA, US
Price Chart
- Market Cap
- $4.68B
- P/E
- -2776.74
- P/S
- 9.49
- P/B
- 9.77
- EV/EBITDA
- 307.95
- Div Yield
- 0.00%
- Gross Margin
- 88.03%
- Op Margin
- -2.84%
- Net Margin
- -0.33%
- ROE
- -0.37%
- ROIC
- 0.90%
- Revenue
- $493.63M · 28.73%
- Net Income
- $-1,636,000 · 94.41%
- EPS
- $-0.03 · 94.76%
- Op Income
- $-14,032,000
- FCF YoY
- 224.26%
- 52W High
- $79.99
- 52W Low
- $36.73
- 50D MA
- $70.53
- 200D MA
- $53.51
- Beta
- 1.03
- Avg Volume
- 2.44M
Get TickerSpark's AI analysis on NARI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 19, 25 | Warner Robert Keith | other | 12,149 |
| Feb 19, 25 | Tu Thomas | other | 7,406 |
| Feb 19, 25 | Tu Thomas | sell | 16,599 |
| Feb 19, 25 | Tu Thomas | sell | 16,231 |
| Feb 19, 25 | Tu Thomas | other | 478,767 |
| Feb 19, 25 | Szyman Catherine M. | other | 22,429 |
| Feb 19, 25 | Szyman Catherine M. | sell | 49,719 |
| Feb 19, 25 | Strange Kevin T | sell | 11,761 |
| Feb 19, 25 | Strange Kevin T | sell | 5,293 |
| Feb 19, 25 | Strange Kevin T | other | 67,502 |
Our NARI coverage
Recent articles, reports, and earnings notes.
No research on NARI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NARI report →Similar companies
Peers in the same neighborhood.